These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 12703118)
1. [Law 10/2002, of April 29, modifying Law 11/1986, of March 20, on patents, for incorporation into Spanish Law of Directive 98/44/CE of the European Parliament and of the Council, of July 6, relating to the legal protection of biotechnology inventions]. Juan Carlos I ; Aznar López JM Rev Derecho Genoma Hum; 2002; (17):229-40. PubMed ID: 12703118 [No Abstract] [Full Text] [Related]
2. Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions. Forum (Genova); 1999; 9(3 Suppl 3):15-24. PubMed ID: 10651517 [No Abstract] [Full Text] [Related]
3. [Genetic comment on patenting of biotechnology inventions in the adaptation of the Spanish Patenting Law to the European framework]. Lacadena JR Rev Derecho Genoma Hum; 2002; (16):199-221. PubMed ID: 12379987 [TBL] [Abstract][Full Text] [Related]
4. Patenting biotechnologies: the European Union Directive 98/44/EC of the European parliament and of the council of 6th July 1998 on the legal protection of biotechnological inventions. Morelli Gradi G Forum (Genova); 1999; 9(3 Suppl 3):25-36. PubMed ID: 10607844 [TBL] [Abstract][Full Text] [Related]
5. Debate on patentability of biotechnological studies in Turkey. Memiş T Rev Derecho Genoma Hum; 2007; (26):121-35. PubMed ID: 18201040 [TBL] [Abstract][Full Text] [Related]
6. Patent protection for stem cell procedures under the law of the European Union. Spranger TM Med Etika Bioet; 2003; 10(1-2):4-8. PubMed ID: 16294439 [TBL] [Abstract][Full Text] [Related]
7. Bio-patents, law and ethics. Critical analysis of the EU biotechnology directive. Van Overwalle G Rev Derecho Genoma Hum; 2003; (19):187-203. PubMed ID: 15032104 [No Abstract] [Full Text] [Related]
8. European Directive on the Legal Protection of Biotechnological Inventions: scope, status and controversies in a nutshell. Hakki MM E Law; 2004 Mar; 11(1):E4. PubMed ID: 16903025 [No Abstract] [Full Text] [Related]
9. Regulating morality through patent law. Critique of the EC Directive. Beyleveld D Rev Derecho Genoma Hum; 2000; (12):141-71. PubMed ID: 11147206 [No Abstract] [Full Text] [Related]
10. Ethics and patentability in biotechnology. Witek R Sci Eng Ethics; 2005 Jan; 11(1):105-11. PubMed ID: 15727006 [TBL] [Abstract][Full Text] [Related]
12. [Legal protection of biotechnological inventions. The European Parliament's perspective]. Palacio Vallelersundi A; Carrasco Pradas DA Rev Derecho Genoma Hum; 1998; (8):71-103. PubMed ID: 15839028 [TBL] [Abstract][Full Text] [Related]
13. Towards harmonization: the European biotechnology patent directive. Curley D J Biolaw Bus; 2002; 5(3):64-8. PubMed ID: 12816122 [TBL] [Abstract][Full Text] [Related]
14. [The European directive 98/44/CE on legal protection of biotechnologic inventions]. Bergel SD Rev Derecho Genoma Hum; 2000; (13):43-78. PubMed ID: 11284124 [TBL] [Abstract][Full Text] [Related]
15. Opinion on Directive 98/44/EC on the legal protection of biotechnical inventions, and its implementation in Sweden. Swedish National Council on Medical Ethics Sci Eng Ethics; 2005 Jan; 11(1):113-5. PubMed ID: 15729767 [TBL] [Abstract][Full Text] [Related]
16. An analysis of moral issues affecting patenting inventions in the life sciences: a European perspective. Crespi RS Sci Eng Ethics; 2000 Apr; 6(2):157-80. PubMed ID: 11273445 [TBL] [Abstract][Full Text] [Related]
17. Research exemption/experimental use in the European Union: patents do not block the progress of science. Jaenichen HR; Pitz J Cold Spring Harb Perspect Med; 2014 Nov; 5(2):a020941. PubMed ID: 25377145 [TBL] [Abstract][Full Text] [Related]
18. Biotechnology patenting policy in the European Union--as exemplified by the development in Germany. Schrell A; Bauser H; Brunner H Adv Biochem Eng Biotechnol; 2007; 107():13-39. PubMed ID: 17522818 [TBL] [Abstract][Full Text] [Related]
19. European opposition to exclusive control over predictive breast cancer testing and the inherent implications for U.S. patent law and public policy: a case study of the Myriad Genetics' BRCA patent controversy. Paradise J Food Drug Law J; 2004; 59(1):133-54. PubMed ID: 15190928 [No Abstract] [Full Text] [Related]
20. Bungled law threatens Italian tech transfer. Meldolesi A Nat Biotechnol; 2001 Nov; 19(11):996-7. PubMed ID: 11689829 [No Abstract] [Full Text] [Related] [Next] [New Search]